MedPath

Nanfang Hospital Southern Medical University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Dapagliflozin Efficacy and Action in PCOS

Phase 3
Completed
Conditions
Polycystic Ovary Syndrome
Interventions
Drug: Placebo
First Posted Date
2019-12-30
Last Posted Date
2023-01-12
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
165
Registration Number
NCT04213677
Locations
🇨🇳

Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis

Phase 4
Conditions
Hematopoietic Stem Cell Transplantation
Interventions
First Posted Date
2019-12-18
Last Posted Date
2019-12-18
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
266
Registration Number
NCT04203108
Locations
🇨🇳

Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis

Not Applicable
Conditions
Cirrhosis, Liver
Interventions
Other: mNGS for pathogen detection
First Posted Date
2019-12-12
Last Posted Date
2019-12-13
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
15
Registration Number
NCT04195724
Locations
🇨🇳

Nanfang Hospital, Guangzhou, Guangdong, China

Withdrawal or Reduction TKIs in CML-CP

Conditions
MMR on 12 Month
Interventions
Drug: withdrawal TKIs or halve TKIs
First Posted Date
2019-10-29
Last Posted Date
2021-09-05
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
100
Registration Number
NCT04143087
Locations
🇨🇳

NanfangH, Guangzhou, Guangdong, China

Early Conversion of Dasatinib in CML-CP Patients

Conditions
Validity and Safety
Interventions
First Posted Date
2019-10-23
Last Posted Date
2020-12-10
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
200
Registration Number
NCT04136015
Locations
🇨🇳

NanfangH, Guangzhou, Guangdong, China

Metagenomic Next-Generation Sequencing for Diagnosis of Ascites Infection in End-stage Liver Diseases

Not Applicable
Conditions
Ascites Infection
Interventions
Device: mNGS for pathogen detection
First Posted Date
2019-10-14
Last Posted Date
2020-08-14
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
300
Registration Number
NCT04125654
Locations
🇨🇳

Nanfang Hospital, Guangzhou, Guangdong, China

Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With Cirrhosis

Conditions
Portal Hypertension
Gastroesophageal Varices
First Posted Date
2019-10-11
Last Posted Date
2019-10-11
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
616
Registration Number
NCT04123509
Locations
🇨🇳

Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

Phase 2
Conditions
Myeloid Tumors
Conditioning
Allogeneic Hematopoietic Stem Cell Transplantation
TP53
Interventions
First Posted Date
2019-10-10
Last Posted Date
2019-10-10
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
196
Registration Number
NCT04123392
Locations
🇨🇳

Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

A Multicenter Prospective Study of Application of Platelet Mapping in Acute-on-chronic-liver Failure in China

Completed
Conditions
Multicenter Prospective Study
Thrombelastography
Platelet
Acute on Chronic Liver Failure
First Posted Date
2019-10-09
Last Posted Date
2020-01-09
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
486
Registration Number
NCT04119973
Locations
🇨🇳

Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Phase 2
Conditions
Unresectable Stage III Non-small Cell Lung Cancer
Interventions
First Posted Date
2019-10-01
Last Posted Date
2019-10-01
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
100
Registration Number
NCT04111913
Locations
🇨🇳

Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath